Accelus Announces New Milestone with Its FlareHawk® Interbody Fusion System Surpassing 15,000 Devices Implanted
October 11, 2022 08:45 ET
|
Accelus
PALM BEACH GARDENS, Fla., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Announces First Surgeries Using FlareHawk® TiHawk11™ Interbody Fusion System
August 15, 2022 08:59 ET
|
Accelus
New expandable interbody enables up to a 34mm-wide footprint from a posterior approach with up to 2cm2 of bone graft contact area through the implant PALM BEACH GARDENS, Fla., Aug. 15, 2022 ...
Accelus Announces Vail-Summit Orthopaedics and Neurosurgery as First Ambulatory Surgery Center to Adopt Remi™ Robotic Navigation System
July 14, 2022 12:37 ET
|
Accelus
PALM BEACH GARDENS, Fla., July 14, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Announces Series D Equity Financing Led by Concord Health Partners (CHP
July 12, 2022 08:15 ET
|
Accelus
• CHP Co-Founder and Partner Joseph Swedish Named to Accelus Board of Directors PALM BEACH GARDENS, Fla., July 12, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology...
Accelus Announces Sales Leadership Appointments, Establishes U.S. East and West Sales Leaders
June 13, 2022 08:45 ET
|
Accelus
Lisa Jacobs promoted to serve as Vice President of SalesJim Fox promoted to East U.S. Vice President of SalesJay Shellhammer promoted to West U.S. Vice President of Sales PALM BEACH GARDENS, Fla.,...
Accelus Receives U.S. FDA 510(k) Clearance for its Toro-L Interbody Fusion System
May 19, 2022 08:35 ET
|
Accelus
PALM BEACH GARDENS, Fla., May 19, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Receives U.S. FDA 510(k) Clearance for its FlareHawk TiHawk11 Interbody Fusion System
May 12, 2022 08:25 ET
|
Accelus
PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Launches TiHawk7™ Titanium-Bonded Multidirectionally Expanding Interbody Cage to Support Endoscopic and MIS Lumbar Fusion Procedures
May 05, 2022 08:20 ET
|
Accelus
PALM BEACH GARDENS, Fla., May 05, 2022 (GLOBE NEWSWIRE) -- Accelus, a medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in...
Sun Sentinel Names Accelus a Winner of the South Florida Top Workplaces 2022 Award
May 02, 2022 08:45 ET
|
Accelus
PALM BEACH GARDENS, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Announces First Procedure Integrating Remi Robotic Navigation System, LineSider Spinal System, and FlareHawk Expandable Interbody Fusion Device Technologies
April 21, 2022 08:00 ET
|
Accelus
PALM BEACH GARDENS, Fla., April 21, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...